Neurological Diseases

Americans belonging to racial, ethnic, or socioeconomic minority groups experienced a higher burden of stroke, according to results from the All of Us Research Program presented at the American Academy of Neurology Annual Meeting.

The new COVID-19 Neuro Databank/Biobank will gather information on COVID-19-related neurological outcomes, according to a press release.

Researchers observed a “remarkably similar” allocation of NIH funding for 46 diseases in multiple body systems, including neurological and cardiovascular diseases, in 2019 compared with 2008 despite changing patterns in burden of disease.

The FDA granted orphan drug designation to AMX0035, an investigational neuroprotective therapy, for Wolfram syndrome, a rare neurodegenerative disease that causes severe neurological disabilities and results in premature death.

The American Heart Association, in collaboration with the Society of Vascular and Interventional Neurology and John Wiley & Sons, announced the launch of a new open-access journal, Stroke: Vascular and Interventional Neurology.

PHILADELPHIA — Biomarkers are enabling the detection of neurological diseases up to 3 decades before a diagnosis would typically occur, Jane Paulsen, PhD FANA, says in this Healio video.